Enter assignee name

EPO Patents = 3

Forward Citations = 8

Loading Chart...

4 inventors (with patents filed for the assignee):

Thomas MacAllister (11 out of 14 patents)

Sven Jacobson (8 out of 42 patents)

Qicai Liu (3 out of 3 patents)

4. Hemant N Joshi (3 out of 4 patents)

11 patents: Sort by Forward Citations

1. 12329761 - Methods of using rho kinase inhibitors to treat alzheimer's disease (2025-06-17),

2. 12290522 - Method of treating amyotrophic lateral sclerosis (2025-05-06),

3. 12128053 - Taste-masking oral formulations of fasudil (2024-10-29),

4. 12115167 - Oral formulations of fasudil with ion exchange resin (2024-10-15),

5. 11944633 - Oral formulations of fasudil with ion exchange resin (2024-04-02),

6. 11865119 - Methods of treating agitation and other dementia-associated behavioral symptoms (2024-01-09),

7. 11779588 - Method of treating amyotrophic lateral sclerosis (2023-10-10),

8. 11771704 - Methods of using rho kinase inhibitors to treat alzheimer's disease (2023-10-03),

9. 11666583 - Methods of treating cortical dementia associated wandering (2023-06-06),

10. 11642352 - Methods of treating wandering in Lewy dody dementia (2023-05-09),

11. 11311553 - Methods of treating 4-repeat tauopathies (2022-04-26),

Woolsey Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for various medical conditions. With a focus on research and development, Woolsey Pharmaceuticals strives to improve patient outcomes and enhance quality of life. The company's team of experts is committed to advancing healthcare through cutting-edge science and technology.

Profile summary based on public USPTO records.